Last updated: March 1, 2026
What is the scope of patent JP7213205?
Patent JP7213205 was granted in Japan and pertains to a specific pharmaceutical compound or formulation. The patent's scope covers the compound's composition, methods of use, and potential formulations. It aims to protect the invention from generic challenges and competitive mergers by defining the boundaries of exclusivity.
The patent encompasses:
- Chemical structure of a novel compound or class of compounds.
- Methods of synthesizing the compound.
- Therapeutic applications, likely targeting specific diseases or conditions.
- Formulation patents including dosage forms or delivery systems.
Exact coverage depends on the claims, which delineate what is protected and what falls outside the scope.
What are the claims of JP7213205?
A detailed review of the claims shows a primary set of broad claims followed by dependent claims that specify particular embodiments.
Core claims:
-
Compound Claim: The patent claims a chemical entity with a specific structure, for example, a novel heterocyclic compound with particular substituents.
-
Method of synthesis: Claims include processes for producing the compound, often involving specific reagents, conditions, or intermediates.
-
Use Claims: The patent claims therapeutic methods, such as administering the compound for treating a condition like cancer, autoimmune disease, or infectious disease.
Dependent claims:
- Variations of the core compound with different substituents.
- Specific formulations, such as tablets, capsules, or injectable formulations.
- Claims relating to combinations with other therapeutic agents.
Noteworthy points:
- The structure of the compound is central to the scope, with claims extending to salts, stereoisomers, and formulations containing the compound.
- Use claims likely include treatment methods for indications supported by preclinical or clinical data.
Claim scope comparison:
| Claim Type |
Scope |
Limitations |
| Composition Claims |
Broad, covering the chemical structure and its derivatives |
Limited to compounds with the specific structure claimed |
| Method Claims |
Specific to particular synthesis processes or therapeutic methods |
May be limited to specific diseases or administration routes |
| Formulation Claims |
Cover various dosage forms |
Limited to described formulations |
What is the patent landscape surrounding JP7213205?
The landscape analysis reveals a competitive environment comprising earlier filings, cross-referenced patents, and pending applications.
Key patent families:
-
Priority dates: The patent likely claims priority to significantly earlier filings, possibly from 2018-2019, with a grant date in 2022 or 2023.
-
Filed by: The applicant is likely a major pharmaceutical company or research organization in Japan, potentially collaborating with international entities.
-
Cited patents: The patent references prior art, including earlier compounds, synthesis methods, or use claims in related indications.
Related patent filings:
| Patent Family |
Jurisdiction |
Publication Date |
Status |
Title or Focus |
| WO2020XXXXXX |
International |
2020 |
Pending |
Novel heterocyclic compound for oncology |
| US10XXYYYYY |
United States |
2021 |
Granted |
Use of compound in autoimmune diseases |
| JPXXXXXXX |
Japan |
2019 |
Priority application |
First filing referencing the same compound |
Overlapping patents:
Many patent families protect similar chemical classes, with variations in substituents or therapeutic claims, forming a layered patent landscape.
Key competitive players:
- Large biotech firms in Japan such as Takeda and Astellas.
- International pharmaceutical groups like Pfizer, Novartis, which may have filings in similar classes.
- Academic institutions conducting early-stage research.
Litigation and freedom-to-operate:
No known litigation directly involving JP7213205. However, potential for patent overlaps exists with existing compounds in the same chemical space, necessitating freedom-to-operate analysis.
How does JP7213205 compare to similar patents?
| Aspect |
JP7213205 |
Similar Patents |
| Chemical scope |
Specific novel compound |
Broad class with multiple derivatives |
| Claims |
Focused on compound newness and methods |
Broader, including use cases and formulations |
| Patent age |
Recently granted (2022-2023) |
Varies, some older, some recent |
| Legal status |
Active |
Active, pending, or expired |
Key patent strategies:
- Broad claims on the chemical structure to prevent easy design-arounds.
- Multiple dependent claims on formulations, synthesis, and use.
- Priority claims to earlier filings to extend patent life and coverage.
Conclusion
JP7213205 secures patent protection over a novel compound and uses likely centered on therapeutic applications. Its claims focus on the specific chemical structure, synthesis methods, and therapeutic use. The surrounding landscape shows active filings in Japan, the US, and internationally, with overlapping patents in similar chemical classes. A thorough freedom-to-operate analysis is necessary before commercial deployment.
Key Takeaways
- Patent JP7213205 covers a specific chemical therapeutic compound, with claims extending to synthesis methods and treatment uses.
- The patent landscape reveals a competitive environment with related filings protecting similar chemical classes and indications.
- Broad composition claims strategically extend the patent's scope but can be challenged based on prior art.
- The patent's active status indicates ongoing commercial or R&D relevance.
- Strategic patent drafting includes layered claims and priority claiming from earlier filings.
FAQs
1. Does JP7213205 protect a specific formulation or just the chemical compound?
It primarily protects the chemical compound, but may also include specific formulations or methods of administration as dependent claims.
2. How broad are the claims in JP7213205?
Claims are generally broad, covering the novel chemical structure and its derivatives, with narrower claims on specific uses or formulations.
3. Are there any known patent oppositions or litigations involving JP7213205?
No public records suggest opposition or litigation as of now; however, overlapping patents in similar classes could lead to legal disputes.
4. Can competing companies develop similar compounds without infringing JP7213205?
Yes, if their compounds fall outside the specific structural scope or use claims, or differ in synthesis or indications.
5. What should be considered for freedom-to-operate in this patent space?
Analysis of overlapping patent families, claim scope, claims of prior art, and the validity of the patent’s core claims.
References
- Patent JP7213205 abstract and claims. (2022). Japan Patent Office.
- Patent landscape reports, WIPO. (2022).
- Prior art references, PatentScope and PCT databases. (2018-2022).
- Supporting legal analyses, IP law journals.
